Top Institutions in Ophthalmology
Leading academic ophthalmology centers with strong retinal disease research programs and clinical trial experience in novel therapies for AMD, including photobiomodulation, are identified based on their history of conducting pivotal clinical trials, translational research in retinal mitochondrial function, and expertise in advanced retinal imaging and therapeutics.
-
#100
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with extensive research in retinal diseases including AMD, and has participated in multiple clinical trials involving novel therapies such as photobiomodulation.
-
#92
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Known for pioneering research in retinal degenerative diseases and advanced imaging techniques, Mass Eye and Ear has contributed significantly to understanding AMD pathophysiology and emerging therapies including light-based treatments.
-
#88
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in retinal disease research with a focus on innovative therapies for AMD and has a robust clinical trials infrastructure supporting novel treatment modalities like photobiomodulation.
-
#85
Doheny Eye Institute, University of California Los Angeles
Los Angeles, CA
Doheny Eye Institute is renowned for its translational research in retinal degenerations and has contributed to clinical studies exploring photobiomodulation and other innovative therapies for dry AMD.
-
#80
Moorfields Eye Hospital
London, N/A
As one of the world's leading eye hospitals, Moorfields has a strong focus on retinal diseases and has been involved in international clinical trials assessing new therapies including photobiomodulation for dry AMD.